GLP-1 benefits: new data confirms what employees want
National survey findings suggest that employers must consider much more than just coverage of medication to achieve successful, sustainable weight loss benefits design. The right strategy integrates clinical guidance, behavioral health support and ongoing monitoring and outcomes measurement.
The cost of bias: Why GLP-1 stigma is a risk you can’t afford to ignore
GLP-1 medications have changed the conversation on obesity. But alongside the breakthroughs, a troubling viewpoint keeps surfacing: that taking them is a shortcut or an “easy way out.” That bias is not harmless. It undermines evidence-based care, discourages people from seeking treatment, and drives up costs for employers and health plans. Bias against GLP-1s is […]
5 Eye-opening Weight Bias Misconceptions That Fuel Misinformation
With growing attention on obesity medicine, we’ve seen an increase in weight-loss misconceptions—particularly around GLP-1 medications. As leaders in health, it’s our responsibility to address these myths with clear, science-backed information that prioritizes the well-being of those we serve. At Wondr Health, we are committed to educating about obesity medicine and helping remove weight bias […]